NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 22 filers reported holding NEUROBO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $51,000 | -81.8% | 108,541 | -52.7% | 0.00% | – |
Q4 2021 | $280,000 | -46.6% | 229,400 | +62.9% | 0.00% | – |
Q3 2021 | $524,000 | +6.5% | 140,800 | -4.6% | 0.00% | – |
Q2 2021 | $492,000 | -36.3% | 147,562 | -15.9% | 0.00% | – |
Q1 2021 | $772,000 | – | 175,439 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 93,376 | $45,000 | 0.03% |
Murchinson Ltd. | 205,256 | $98,000 | 0.02% |
Mount Yale Investment Advisors, LLC | 57,425 | $28,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 40,496 | $19,000 | 0.00% |
UBS Group AG | 3,066 | $1,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 240 | $0 | 0.00% |
WELLS FARGO & COMPANY/MN | 356 | $0 | 0.00% |
NORTHERN TRUST CORP | 17,155 | $8,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 438 | $0 | 0.00% |